Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Tarceva

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tarceva was produced by Roche and Astellas.

Prospects for Lilly’s Verzenio hit by botched lung cancer trial

Prospects for Lilly’s Verzenio hit by botched lung cancer trial The study compared Verzenio to Roche’s EGFR inhibitor Tarceva (erlotinib), which when it started in 2015 was the only agent indicated for second- and third-line therapy in advanced NSCLC,

AZ starts pursuit of lung cancer indication for Imfinzi

AZ starts pursuit of lung cancer indication for Imfinzi In that study, patients on Tagrisso had a PFS of 18.9 months, compared to just over 10 months for first-generation EGFR-targeting drugs, Roche's Tarceva (erlotinib) and

AZ buoyed by latest lung cancer data at ESMO

AZ buoyed by latest lung cancer data at ESMO to just over 10 months for first-generation EGFR-targeting drugs, Roche's Tarceva (erlotinib) and AZ's own Iressa (gefitinib).

AZ gets rapid approval in China for Tagrisso

AZ gets rapid approval in China for Tagrisso Moreover, nearly two thirds patients whose disease progresses after treatment with a first-line EGFR inhibitor - such as Iressa, Roche/Astellas' $2bn-a-year Tarceva (erlotinib) and Boehringer Ingelheim's Giotrif

Novocure’s chief commercial officer to step down

Novocure’s chief commercial officer to step down Previously, he was senior vice president for sales and marketing at OSI Pharmaceuticals, where he led the global commercialisation of Tarceva (erlotinib) from 2003 to 2011.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...

Infographics